Treatment planning comparison between conformal radiotherapy and helical tomotherapy in the case of locally advanced-stage NSCLC

Radiotherapy and Oncology

Volumn 88, Issue 3, 2008, Pages 310-318

  Cattaneo, Giovanni Mauro ^a   Dell'Oca, Italo ^a   Broggi, Sara ^a   Fiorino, Claudio ^a   Perna, Lucia ^a   Pasetti, Marcella ^a   Sangalli, Giulia ^a   di Muzio, Nadia ^a   Fazio, Ferruccio ^a   Calandrino, Riccardo ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Intensity modulation; Non small cell lung cancer; NTCP; Radiotherapy; Three dimensional conformal

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER LOCALIZATION; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; HELICAL TOMOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; LUNG NON SMALL CELL CANCER; LUNG PARENCHYMA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION PNEUMONIA; RISK FACTOR; THREE DIMENSIONAL IMAGING; TREATMENT PLANNING;

AGED; ALGORITHMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 52049102221     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2008.06.006     Document Type: Article

References (63)

1. AAPM Report No. 85. Tissue inhomogeneity corrections for megavoltage photon beams. Medical Physics Publishing; 2004.
2. Arriagada R., Komaki R., and Cox J.D. Radiation dose escalation in non small carcinoma of the lung. Semin Radiat Oncol 14 (2004) 287-291
3. Belderbos J., Heemsbergen W., Hoogeman M., et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 75 (2005) 157-164
4. Bosmans G., Bruijsen J., Dekker A., et al. An "in silico" clinical trial comparing free breathing, slow and respiration correlated computed tomography in lung cancer patients. Radiother Oncol 81 (2006) 73-80
5. Bortfeld T., Jiang S.B., and Rietzel E. Effects of motion on the total dose distribution. Semin Radiat Oncol 14 (2004) 41-51
6. Bradley J., Thorstad W.L., Mutic S., et al. Impact of FDG-PET on radiation therapy volume delineation in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 59 (2004) 78-86
7. Bragg C.M., Wingate K., and Conway J. Clinical implications of the anisotropic analytical algorithm for IMRT treatment planning and verification. Radiother Oncol 86 (2008) 276-286
8. Burman C., Kutcher G.J., Emami B., and Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
9. Byhardt R.W., Scott C., Sause W.T., et al. Response, toxicity, failure patterns, and survival in five Radiation Therapy Oncology Group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 42 (1998) 469-476
10. Ceresoli G.L., Cattaneo G.M., Castellone P., et al. Role of computed tomography and 18FDG PET image fusion in conformal radiotherapy of NSCLC: a comparison with standard techniques with and without elective nodal irradiation. Tumori 93 (2007) 88-96
11. Cozzi L., Clivio A., Bauman G., Cora S., Nicolini G., Pellegrini R., et al. Comparison of advanced irradiation techniques with photons for benign intracranial tumors. Radiother Oncol 80 (2006) 268-273
12. Curran W, Scott C, Langer C. Phase III comparison of sequential versus concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer: report of Radiation Therapy Oncology Group 9410, 9th world conference on lung cancer. Lung Cancer 2000;29-93.
13. De Jaeger K., Hoogeman M.S., Engelsman M., et al. Incorporating an improved dose-calculation algorithm in conformal radiotherapy of lung cancer: re-evaluation of dose in normal lung tissue. Radiother Oncol 69 (2003) 1-10
14. Ding G.H., Duggan D.M., Lu B., et al. Impact of inhomogeneity corrections on dose coverage in the treatment of lung cancer using stereotactic body radiation therapy. Med Phys 34 (2007) 2985-2994
15. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
16. Fiorino C., Dell'Oca I., Pierelli A., Broggi S., De Martin E., Di Muzio N., et al. Significant improvement in normal tissue sparing and target coverage for head and neck cancer by means of helical tomotherapy. Radiother Oncol 78 (2006) 276-282
17. Fowler J.F., and Chappel R. Non-small cell lung tumors repopulate rapidly during radiation therapy. Int J Radiat Oncol Biol Phys 46 (1996) 516-517 [Letter to the editor]
18. Fogliata A., Nicolini G., Vanetti E., Clivio A., and Cozzi L. Dosimetric validation of the anisotropic analytical algorithm for photon dose calculation: fundamental characterization in water. Phys Med Biol 51 (2006) 1421-1438
19. Fogliata A., Vanetti E., Albers D., et al. On the dosimetric behavior of photon dose calculation algorithms in the presence of simple geometric heterogeneities: comparison with Monte Carlo calculations. Phys Med Biol 53 (2007) 1363-1385
20. Furuse K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
21. Gagliardi G., Lax I., and Rutqvist L.E. Partial irradiation of the heart. Semin Radiat Oncol 11 (2001) 224-233
22. Gould M.K., Maclean C.C., Kuschner W.G., et al. Accuracy of PET for diagnosis of pulmonary nodules and mass lesions: a meta analysis. JAMA 285 (2001) 914-924
23. Grills I.S., Yan D., Martinez A.A., et al. Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. Int J Radiat Oncol Biol Phys 57 (2003) 875-890
24. Iori M., Cattaneo G.M., Cagni E., Fiorino C., Borasi G., Calandrino R., et al. Dose-volume and biological-model based comparison between helical tomotherapy and (inverse-planned) IMAT for prostate tumours. Radiother Oncol 88 (2008) 34-45
25. Jeremic B., Shibamoto Y., Acimovic L., et al. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small cell lung cancer. J Clin Oncol 13 (1995) 452-458
26. Jeremic K., Fukuoka M., Kawahara M., et al. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol 17 (1999) 2692-2699
27. Källman P., Agren A., and Brahme A. Tumor and normal tissue responses to fractionated non uniform dose delivery. Int J Radiat Oncol Biol Phys 62 (1992) 249-262
28. Kanagaki B., Read P.W., Molloy J.A., et al. A motion phantom study on helical tomotherapy: the dosimetric impacts of delivery technique and motion. Phys Med Biol 52 (2007) 243-255
29. Knöös T., Wieslander E., Cozzi L., et al. Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations. Phys Med Biol 51 (2006) 5785-5807
30. Kong F.M., Pan C., Eisbruch A., and Ten Haken R. Physical models and simpler dosimetric descriptors of radiation late toxicity. Semin Radiat Oncol 17 (2007) 108-120
31. Kron T., Grigorof G., Yu E., et al. Planning evaluation of radiotherapy for complex lung cancer cases using helical tomotherapy. Phys Med Biol 49 (2004) 3675-3695
32. Kutcher G.J., Burman C., Brewster L., et al. Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluation. Int J Radiat Oncol Biol Phys 21 (1991) 137-147
33. Le Chevalier T., Arriagada R., Quoix E., et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small cell lung cancer. First analysis of randomizes trial in 353 patients. J Natl Cancer Inst 83 (1991) 417-423
34. Liu H.H., Wang X., Dong L., et al. Feasibility of sparing lung and other thoracic structures with intensity-modulated radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1268-1279
35. Lyman J.T. Complication probability as assessed from dose-volume histograms. Radiat Res Suppl 8 (1985) S13-S19
36. Mackie T.R., Holmes R.W., Swedloff S., et al. Tomotherapy: a new concept for delivery of conformal radiotherapy. Med Phys 20 (1993) 1709-1719
37. Mackie TR, Olivera GH, Reckwerdt PJ, Shepard DM. Convolution/superposition photon dose calculation. In: Shui AS, Mellenberg DE, editors. General practice of radiation oncology physics in the 21st century. Madison (WI): Published for AAPM by Medical Physics Publishing; 2000. p. 39-56.
38. Martel M.K., Ten Haken R.R., Hazuka M.B., et al. Estimation of tumor control probability model parameters from 3D dose distributions of non-small cell lung cancer patients. Lung Cancer 24 (1999) 31-37
39. Mehta M., Scrimger R., Mackie R.T., et al. A new approach to dose escalation in non-small cell lung cancer. Int J Radiat Oncol Biol Phys 49 (2001) 23-33
40. 18F]FDG-PET and co-registered CT on clinical target volume definition of advanced non-small cell lung cancer. Q J Nucl Med Mol Imaging 49 (2005) 259-266
41. Morgan A.M., Knöös T., NcNee S.G., Evans C.J., and Thwaites D.I. Clinical implications of the implementation of advanced treatment planning algorithms for thoracic treatments. Radiother Oncol 86 (2008) 48-54
42. Murshed H., Liu H.H., Liao Z., et al. Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 58 (2004) 1258-1267
43. Nestle U., Kremp S., and Grosu A.L. Practical integration of [18F]-FDG-PET and PET-CT in the planning of radiotherapy for NSCLC: the technical basis, ICRU-target volumes, problems, perspectives. Radiother Oncol 81 (2006) 209-225
44. Penland S.K., and Socinski M.A. Management of unresectable stage III NSCLC: the role of combined chemoradiation. Semin Radiat Oncol (2004) 326-334
45. Rancati T., Ceresoli G.L., Gagliardi G., Schipani S., and Cattaneo G.M. Factors predicting radiation pneumonitis in lung cancer patients: a retrospective study. Radiother Oncol 67 (2003) 275-283
46. Rizzo G., Cattaneo G.M., Castellone P., et al. Multi-modal medical image integration to optimize radiotherapy planning in lung cancer treatment. Ann Biomed Eng 32 (2004) 1399-1408
47. Rodrigues G., Lock M., D'Souza D., et al. Prediction of radiation pneumonitis by dose-volume histogram parameters in lung cancer: a systematic review. Radiother Oncol 71 (2004) 127-138
48. Rodrigues G., Yartsev S., Chen J., Wong E., D'Souza D., Lock M., et al. A comparison of prostate IMRT and helical tomotherapy class solutions. Radiother Oncol 80 (2006) 374-377
49. Sanchez-Nieto B., and Nahum A.E. BIOPLAN: software for the biological evaluation of radiotherapy treatment plans. Med Dosim 25 (2000) 71-76
50. Schwarz M., Van der Geer J., van Herk M., et al. Impact of geometrical uncertainties on 3D CRT and IMRT dose distributions for lung cancer treatment. J Radiat Oncol Biol Phys 56 (2006) 1260-1269
51. Scrimger R.A., Tomé W.A., Olivera G.H., et al. Reduction in radiation doses to lung and other normal tissues using helical tomotherapy to treat lung cancer, in comparison to conventional field arrangements. Am J Clin Oncol 26 (2003) 70-78
52. Senan S., De Ruysscher D., Giraud P., et al. Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer. Radiother Oncol 71 (2004) 139-146
53. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis. NTCP. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
54. Singh A.K., Lockett M.A., and Bradley J.D. Predictor of radiation-induced esophageal toxicity in patients with NSCLC treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 55 (2003) 337-341
55. Sterpin E., Tomsej M., De Smedt B., et al. Monte Carlo evaluation of the AAA treatment planning algorithm in a heterogeneous multiplayer phantom and IMRT clinical treatments for an Elekta SL25 linear accelerator. Med Phys 34 (2007) 1665-1677
56. Sterzing F., Sroka-Perez G., Schubert K., Münter M.W., Thieke C., Huber P., et al. Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT. Radiother Oncol 86 (2008) 251-257
57. Tomé W.A., Jaradat H.A., Nelson I.A., et al. Helical tomotherapy: image guidance and adaptive dose guidance. Front Radiat Ther Oncol 40 (2007) 162-178
58. Ulmer W., Pyyry J., and Kaissl W. A 3D photon superposition/convolution algorithm and its foundation on results of Monte Carlo calculations. Phys Med Biol 50 (2005) 1767-1790
59. Van Baardwijk A., Baumert B.G., Bosmans G., et al. The current status of FDG-PET in tumour volume definition in radiotherapy treatment planning. Cancer Treat Rev 32 (2006) 245-260
60. Vanderstraeten B., Reynaert N., Paelinck L., et al. Accuracy of patient dose calculation for lung IMRT: a comparison of Monte Carlo, convolution/superimposition, and pencil beam computations. Med Phys 33 (2006) 3149-3158
61. Van Esch A., Tillikainen L., Pyykkonen J., et al. Testing of the Analytical Anisotropic Algorithm for photon dose calculation. Med Phys 33 (2006) 4130-4186
62. Yang J.N., Mackie T.R., Reckwerdt P., et al. An investigation of tomotherapy beam delivery. Med Phys 24 (1997) 425-436
63. Yartsev S., Chen J., Yu E., et al. Comparative planning evaluation of intensity-modulated radiotherapy techniques for complex lung cancer cases. Radiother Oncol 78 (2006) 169-176